| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin-Secreting Cells | 33 | 2025 | 430 | 3.470 |
Why?
|
| Diabetes Mellitus, Type 1 | 25 | 2025 | 574 | 3.200 |
Why?
|
| Arachidonate 12-Lipoxygenase | 10 | 2025 | 26 | 2.820 |
Why?
|
| Islets of Langerhans | 16 | 2022 | 555 | 1.920 |
Why?
|
| Lipoxygenase Inhibitors | 3 | 2025 | 36 | 1.310 |
Why?
|
| Diabetes Mellitus, Experimental | 7 | 2022 | 192 | 1.260 |
Why?
|
| Arachidonate 15-Lipoxygenase | 8 | 2025 | 18 | 1.250 |
Why?
|
| Cell Death | 5 | 2021 | 261 | 1.230 |
Why?
|
| Insulin | 15 | 2021 | 1166 | 1.170 |
Why?
|
| Obesity | 6 | 2025 | 1014 | 1.150 |
Why?
|
| DNA Methylation | 8 | 2021 | 677 | 0.970 |
Why?
|
| Diet, High-Fat | 8 | 2025 | 128 | 0.930 |
Why?
|
| Blood Glucose | 7 | 2025 | 855 | 0.890 |
Why?
|
| DNA | 6 | 2018 | 1314 | 0.840 |
Why?
|
| Inflammation | 5 | 2025 | 1024 | 0.810 |
Why?
|
| Mice | 45 | 2025 | 12136 | 0.790 |
Why?
|
| Peptide Initiation Factors | 7 | 2025 | 30 | 0.710 |
Why?
|
| Protein Precursors | 3 | 2018 | 138 | 0.660 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 6 | 2025 | 21 | 0.630 |
Why?
|
| Disease Models, Animal | 7 | 2024 | 2449 | 0.620 |
Why?
|
| Polyamines | 3 | 2024 | 38 | 0.620 |
Why?
|
| Animals | 51 | 2025 | 28053 | 0.620 |
Why?
|
| RNA-Binding Proteins | 7 | 2025 | 284 | 0.590 |
Why?
|
| Mice, Inbred NOD | 14 | 2024 | 206 | 0.580 |
Why?
|
| Oxidative Stress | 5 | 2022 | 464 | 0.580 |
Why?
|
| Insulin Resistance | 7 | 2022 | 375 | 0.550 |
Why?
|
| Biomarkers | 7 | 2025 | 1847 | 0.530 |
Why?
|
| Pancreas | 4 | 2025 | 252 | 0.510 |
Why?
|
| Macrophages | 5 | 2025 | 601 | 0.510 |
Why?
|
| Endoplasmic Reticulum | 3 | 2012 | 259 | 0.480 |
Why?
|
| Cell-Free Nucleic Acids | 3 | 2021 | 84 | 0.470 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2022 | 1210 | 0.460 |
Why?
|
| Lysine | 5 | 2025 | 181 | 0.450 |
Why?
|
| Mice, Inbred C57BL | 14 | 2025 | 3375 | 0.440 |
Why?
|
| Islets of Langerhans Transplantation | 4 | 2020 | 244 | 0.430 |
Why?
|
| Zebrafish Proteins | 3 | 2025 | 150 | 0.410 |
Why?
|
| Diabetes Mellitus | 2 | 2020 | 760 | 0.390 |
Why?
|
| Unfolded Protein Response | 4 | 2024 | 46 | 0.380 |
Why?
|
| Mice, Knockout | 11 | 2021 | 2097 | 0.370 |
Why?
|
| Stress, Physiological | 1 | 2012 | 245 | 0.330 |
Why?
|
| Dietary Fats | 3 | 2020 | 136 | 0.320 |
Why?
|
| Trans-Activators | 4 | 2017 | 443 | 0.280 |
Why?
|
| Glucose | 3 | 2019 | 683 | 0.270 |
Why?
|
| Homeodomain Proteins | 4 | 2017 | 561 | 0.260 |
Why?
|
| Male | 21 | 2025 | 43927 | 0.240 |
Why?
|
| Protein Biosynthesis | 3 | 2017 | 384 | 0.230 |
Why?
|
| Apoptosis | 3 | 2020 | 1745 | 0.220 |
Why?
|
| Glucose Intolerance | 3 | 2014 | 99 | 0.220 |
Why?
|
| eIF-2 Kinase | 1 | 2024 | 47 | 0.220 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2023 | 6 | 0.220 |
Why?
|
| Eflornithine | 3 | 2024 | 16 | 0.210 |
Why?
|
| Endoplasmic Reticulum Stress | 3 | 2022 | 85 | 0.210 |
Why?
|
| Alternative Splicing | 1 | 2025 | 214 | 0.210 |
Why?
|
| RNA Splicing | 1 | 2025 | 157 | 0.210 |
Why?
|
| Humans | 30 | 2025 | 92339 | 0.210 |
Why?
|
| Female | 20 | 2025 | 47893 | 0.210 |
Why?
|
| PPAR gamma | 2 | 2016 | 74 | 0.200 |
Why?
|
| Zebrafish | 5 | 2025 | 325 | 0.200 |
Why?
|
| Cytokines | 3 | 2024 | 843 | 0.190 |
Why?
|
| RNA, Messenger | 3 | 2019 | 2038 | 0.190 |
Why?
|
| Receptors, CXCR3 | 1 | 2021 | 12 | 0.180 |
Why?
|
| Naphthalenes | 2 | 2019 | 40 | 0.180 |
Why?
|
| Creatine | 1 | 2021 | 26 | 0.180 |
Why?
|
| Isoxazoles | 2 | 2019 | 77 | 0.170 |
Why?
|
| Lipoxygenases | 1 | 2020 | 3 | 0.170 |
Why?
|
| Signal Transduction | 5 | 2020 | 3509 | 0.170 |
Why?
|
| Organogenesis | 1 | 2020 | 50 | 0.170 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2020 | 9 | 0.170 |
Why?
|
| Pediatric Obesity | 1 | 2020 | 28 | 0.160 |
Why?
|
| Cell Movement | 1 | 2023 | 801 | 0.160 |
Why?
|
| Cell Communication | 1 | 2021 | 206 | 0.160 |
Why?
|
| Adipogenesis | 1 | 2019 | 41 | 0.160 |
Why?
|
| Adipose Tissue, White | 1 | 2019 | 27 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 137 | 0.160 |
Why?
|
| Intravital Microscopy | 1 | 2019 | 13 | 0.160 |
Why?
|
| Thermogenesis | 1 | 2019 | 46 | 0.160 |
Why?
|
| Adipose Tissue, Brown | 1 | 2019 | 94 | 0.160 |
Why?
|
| Models, Biological | 2 | 2017 | 1786 | 0.160 |
Why?
|
| Aging | 2 | 2016 | 741 | 0.150 |
Why?
|
| Glutamate Decarboxylase | 1 | 2019 | 32 | 0.150 |
Why?
|
| Calcium Channels, R-Type | 1 | 2018 | 4 | 0.150 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 2007 | 0.150 |
Why?
|
| Collagen | 1 | 2020 | 303 | 0.150 |
Why?
|
| Tissue Survival | 1 | 2018 | 13 | 0.150 |
Why?
|
| rho-Associated Kinases | 1 | 2019 | 161 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2020 | 331 | 0.150 |
Why?
|
| Collagen Type I | 1 | 2018 | 74 | 0.140 |
Why?
|
| Streptozocin | 2 | 2019 | 55 | 0.140 |
Why?
|
| Graft Survival | 2 | 2020 | 935 | 0.140 |
Why?
|
| Hydroxyquinolines | 1 | 2017 | 4 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 221 | 0.140 |
Why?
|
| Calcitriol | 1 | 2018 | 173 | 0.140 |
Why?
|
| Thiophenes | 1 | 2017 | 44 | 0.140 |
Why?
|
| Receptors, Calcitriol | 1 | 2018 | 130 | 0.140 |
Why?
|
| Cell Proliferation | 3 | 2025 | 1724 | 0.130 |
Why?
|
| Calcium | 2 | 2018 | 1183 | 0.130 |
Why?
|
| Mice, Inbred Strains | 2 | 2013 | 297 | 0.130 |
Why?
|
| Thiazolidinediones | 1 | 2016 | 75 | 0.130 |
Why?
|
| Endothelial Cells | 1 | 2019 | 472 | 0.130 |
Why?
|
| Energy Metabolism | 2 | 2019 | 302 | 0.120 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 531 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2021 | 1689 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 736 | 0.120 |
Why?
|
| Mice, SCID | 2 | 2013 | 265 | 0.120 |
Why?
|
| DNA Damage | 1 | 2017 | 381 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 504 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 291 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 888 | 0.120 |
Why?
|
| Sirtuins | 1 | 2016 | 74 | 0.110 |
Why?
|
| Glutathione Peroxidase | 1 | 2014 | 24 | 0.110 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 69 | 0.110 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2014 | 34 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2017 | 429 | 0.110 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2014 | 43 | 0.110 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 181 | 0.110 |
Why?
|
| Hyperplasia | 1 | 2014 | 152 | 0.110 |
Why?
|
| Liver | 2 | 2017 | 1228 | 0.110 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 163 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2019 | 575 | 0.110 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 155 | 0.110 |
Why?
|
| DNA Repair | 1 | 2016 | 367 | 0.110 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2013 | 10 | 0.100 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2013 | 78 | 0.100 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2013 | 36 | 0.100 |
Why?
|
| Adipose Tissue | 3 | 2021 | 267 | 0.100 |
Why?
|
| Oxygenases | 1 | 2013 | 13 | 0.100 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 50 | 0.100 |
Why?
|
| Graft Rejection | 1 | 2019 | 1110 | 0.100 |
Why?
|
| Necrosis | 1 | 2013 | 210 | 0.100 |
Why?
|
| Gene Deletion | 3 | 2019 | 354 | 0.100 |
Why?
|
| Th1 Cells | 1 | 2013 | 168 | 0.100 |
Why?
|
| Cytological Techniques | 1 | 2012 | 31 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2024 | 2369 | 0.100 |
Why?
|
| Triazoles | 1 | 2013 | 108 | 0.100 |
Why?
|
| Collagenases | 1 | 2012 | 42 | 0.100 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 106 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 289 | 0.100 |
Why?
|
| Ornithine Decarboxylase | 2 | 2023 | 10 | 0.100 |
Why?
|
| Endopeptidases | 1 | 2012 | 117 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1310 | 0.090 |
Why?
|
| Genomics | 1 | 2017 | 807 | 0.090 |
Why?
|
| Cell Differentiation | 2 | 2019 | 1607 | 0.090 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 2671 | 0.090 |
Why?
|
| Haploinsufficiency | 1 | 2011 | 68 | 0.090 |
Why?
|
| Phenotype | 2 | 2021 | 2502 | 0.080 |
Why?
|
| Cell Survival | 3 | 2020 | 1008 | 0.080 |
Why?
|
| Primary Cell Culture | 2 | 2021 | 81 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1939 | 0.080 |
Why?
|
| Euchromatin | 1 | 2009 | 6 | 0.080 |
Why?
|
| Diabetes Complications | 1 | 2010 | 173 | 0.080 |
Why?
|
| Manganese | 1 | 2008 | 56 | 0.080 |
Why?
|
| Autophagy | 2 | 2022 | 169 | 0.070 |
Why?
|
| Crosses, Genetic | 2 | 2019 | 172 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2025 | 1901 | 0.070 |
Why?
|
| Interleukin-1beta | 2 | 2020 | 85 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 3054 | 0.070 |
Why?
|
| Weight Gain | 2 | 2020 | 124 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2017 | 2905 | 0.060 |
Why?
|
| Adult | 6 | 2025 | 27538 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2020 | 454 | 0.060 |
Why?
|
| Child | 3 | 2025 | 7309 | 0.060 |
Why?
|
| Lymph Nodes | 2 | 2022 | 552 | 0.060 |
Why?
|
| Young Adult | 3 | 2025 | 6630 | 0.060 |
Why?
|
| Algorithms | 1 | 2013 | 1960 | 0.060 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2024 | 16 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2018 | 667 | 0.060 |
Why?
|
| Leukotriene B4 | 1 | 2023 | 14 | 0.050 |
Why?
|
| Spermine | 1 | 2024 | 25 | 0.050 |
Why?
|
| Ornithine Decarboxylase Inhibitors | 1 | 2023 | 4 | 0.050 |
Why?
|
| Putrescine | 1 | 2023 | 7 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2025 | 284 | 0.050 |
Why?
|
| Cell Line | 2 | 2020 | 2505 | 0.050 |
Why?
|
| Middle Aged | 5 | 2020 | 27043 | 0.050 |
Why?
|
| Pancreatic Hormones | 1 | 2022 | 15 | 0.050 |
Why?
|
| Protein Binding | 2 | 2017 | 1514 | 0.050 |
Why?
|
| Glucose Tolerance Test | 2 | 2016 | 232 | 0.050 |
Why?
|
| Neoplasms | 1 | 2017 | 3124 | 0.050 |
Why?
|
| Machine Learning | 1 | 2025 | 298 | 0.050 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2021 | 14 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2017 | 768 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2017 | 729 | 0.040 |
Why?
|
| Amidinotransferases | 1 | 2021 | 5 | 0.040 |
Why?
|
| Coenzyme A Ligases | 1 | 2021 | 8 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2021 | 184 | 0.040 |
Why?
|
| Diet, Fat-Restricted | 1 | 2020 | 30 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 2020 | 63 | 0.040 |
Why?
|
| Diet, Western | 1 | 2020 | 42 | 0.040 |
Why?
|
| Parathyroid Hormone | 1 | 2021 | 222 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2020 | 101 | 0.040 |
Why?
|
| Laboratory Proficiency Testing | 1 | 2020 | 5 | 0.040 |
Why?
|
| Injections, Subcutaneous | 1 | 2020 | 128 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2013 | 334 | 0.040 |
Why?
|
| B7-H1 Antigen | 1 | 2022 | 285 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 107 | 0.040 |
Why?
|
| Cyclin D2 | 1 | 2019 | 20 | 0.040 |
Why?
|
| Biological Assay | 1 | 2020 | 81 | 0.040 |
Why?
|
| RNA Interference | 1 | 2021 | 385 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2021 | 171 | 0.040 |
Why?
|
| Allografts | 1 | 2020 | 197 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 562 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 139 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2019 | 266 | 0.040 |
Why?
|
| Fibrillar Collagens | 1 | 2018 | 10 | 0.040 |
Why?
|
| Culture Techniques | 1 | 2018 | 89 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2019 | 140 | 0.040 |
Why?
|
| Polymerization | 1 | 2018 | 34 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 2019 | 77 | 0.040 |
Why?
|
| Dermis | 1 | 2018 | 28 | 0.040 |
Why?
|
| C-Peptide | 1 | 2018 | 184 | 0.040 |
Why?
|
| Adolescent | 2 | 2025 | 9495 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2019 | 311 | 0.040 |
Why?
|
| Proteomics | 1 | 2020 | 246 | 0.040 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2017 | 14 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2021 | 441 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 1232 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 283 | 0.030 |
Why?
|
| Vitamin D Deficiency | 1 | 2018 | 105 | 0.030 |
Why?
|
| Homeostasis | 1 | 2019 | 452 | 0.030 |
Why?
|
| Whole Genome Sequencing | 1 | 2017 | 103 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 521 | 0.030 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2016 | 20 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 3514 | 0.030 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2016 | 18 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2018 | 998 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 607 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2017 | 308 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2016 | 68 | 0.030 |
Why?
|
| Fatty Acids, Volatile | 1 | 2016 | 36 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2017 | 296 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1142 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 1052 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2016 | 183 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2016 | 509 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 800 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 315 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2015 | 111 | 0.030 |
Why?
|
| Polyribosomes | 1 | 2014 | 21 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2016 | 251 | 0.030 |
Why?
|
| Glycolysis | 1 | 2016 | 184 | 0.030 |
Why?
|
| 5' Untranslated Regions | 1 | 2014 | 50 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 277 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 105 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 280 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 4066 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 499 | 0.030 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 36 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 1194 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2013 | 33 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2793 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1733 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2017 | 702 | 0.030 |
Why?
|
| Adiposity | 1 | 2013 | 77 | 0.030 |
Why?
|
| Software | 1 | 2017 | 676 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 538 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 109 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2017 | 1112 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 87 | 0.030 |
Why?
|
| Guanine | 1 | 2013 | 207 | 0.020 |
Why?
|
| Th17 Cells | 1 | 2013 | 95 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2013 | 208 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2013 | 313 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2013 | 111 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 19951 | 0.020 |
Why?
|
| Mitochondria | 1 | 2016 | 597 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 3776 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 2075 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 806 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 89 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 707 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 3872 | 0.020 |
Why?
|
| Transcription Factor CHOP | 1 | 2010 | 14 | 0.020 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 2010 | 10 | 0.020 |
Why?
|
| Thapsigargin | 1 | 2010 | 55 | 0.020 |
Why?
|
| Oxygen | 1 | 2016 | 763 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2978 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3018 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2010 | 164 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2010 | 232 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1164 | 0.020 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2009 | 12 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2009 | 26 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2009 | 56 | 0.020 |
Why?
|
| Protein Transport | 1 | 2010 | 430 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2015 | 3805 | 0.020 |
Why?
|
| Glycosuria | 1 | 2007 | 4 | 0.020 |
Why?
|
| Tail | 1 | 2007 | 31 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2007 | 50 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 651 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2007 | 211 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 542 | 0.020 |
Why?
|
| Mutation | 1 | 2017 | 4212 | 0.020 |
Why?
|
| Genome | 1 | 2007 | 399 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2007 | 1078 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 2396 | 0.010 |
Why?
|